Literature DB >> 29226200

Long-term Results of Osteoarticular Allograft Reconstruction in Children with Distal Femoral Bone Tumors.

Khodamorad Jamshidi1, Mehrdad Bahrabadi1, Alireza Mirzaei1.   

Abstract

BACKGROUND: There is no consensus regarding the best method of reconstruction in pediatric population following the wide resection of malignant bone tumors. More exploration of the complications of osteoarticular reconstruction leads to less existing controversy of this type of reconstruction, which is the main point of this article.
METHODS: Long-term outcomes and complications of osteoarticular allograft reconstruction of primary distal femoral bone sarcomas in 22 children with mean age of 10.7 years old were reviewed in this study. Musculoskeletal Tumor Society (MSTS) scoring system was used for functional evaluation of the allografts.
RESULTS: With an average follow-up time of 81 months, the outcomes of 16 patients with allografts at the final follow up were evaluated. As expected, Limb length discrepancy (LLD) was observed in all patients (mean LLD= 2.73cm), which was significantly correlated to allograft survival time (P<0.001). Degenerative joint disease (DJD) was also seen in all patients and its grade was also significantly correlated to allograft survival time (P<0.001). The mean MSTS-score was 74% at the latest follow-up, ranging from 60% to 90%. Five and 10 year survival rate of allografts were found to be 93.3% and 62.2%, respectively.
CONCLUSION: Osteoarticular allograft reconstruction could result in several complications including DJD. Despite its considerable biologic advantage over endoprosthesis, osteoarticular allograft reconstruction is a long-lasting but still a temporary solution before performing megaprosthesis. This allows patients to preserve their remaining physis for limb growth and become old enough for an adult megaprosthesis.

Entities:  

Keywords:  Distal Femoral Tumor; Osteoarticular Allograft; Pediatric

Year:  2017        PMID: 29226200      PMCID: PMC5712395     

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  16 in total

1.  An abbreviated history of orthopaedic oncology in North America.

Authors:  W F Enneking
Journal:  Clin Orthop Relat Res       Date:  2000-05       Impact factor: 4.176

2.  Growth and predictions of growth in the lower extremities.

Authors:  M ANDERSON; W T GREEN; M B MESSNER
Journal:  J Bone Joint Surg Am       Date:  1963-01       Impact factor: 5.284

3.  NCCN sarcoma practice guidelines. National Comprehensive Cancer Network.

Authors:  G D Demetri; R Pollock; L Baker; S Balcerzak; E Casper; C Conrad; D Fein; R Hutchinson; K Schupak; I Spiro; L Wagman
Journal:  Oncology (Williston Park)       Date:  1998-07       Impact factor: 2.990

4.  Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography, and CT correlated with pathologic examination.

Authors:  J L Bloem; A H Taminiau; F Eulderink; J Hermans; E K Pauwels
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

5.  Lower limb salvage surgery: modular endoprosthesis in bone tumour treatment.

Authors:  D Orlic; M Smerdelj; R Kolundzic; M Bergovec
Journal:  Int Orthop       Date:  2006-08-08       Impact factor: 3.075

6.  Seven-year experience of using Repiphysis expandable prosthesis in children with bone tumors.

Authors:  Said Saghieh; Miguel R Abboud; Samar A Muwakkit; Raya Saab; Bhaskar Rao; Rachid Haidar
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

7.  Outcome of expandable prostheses in children.

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Elisa Pala; Matteo Romantini; Marco Manfrini; Mario Mercuri
Journal:  J Pediatr Orthop       Date:  2013 Apr-May       Impact factor: 2.324

8.  Allograft reconstruction after sarcoma resection in children younger than 10 years old.

Authors:  D Luis Muscolo; Miguel A Ayerza; Luis Aponte-Tinao; German Farfalli
Journal:  Clin Orthop Relat Res       Date:  2008-05-28       Impact factor: 4.176

9.  Long-term results of allograft replacement in the management of bone tumors.

Authors:  H J Mankin; M C Gebhardt; L C Jennings; D S Springfield; W W Tomford
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

10.  Massive allografts in the treatment of osteosarcoma and Ewing sarcoma in children and adolescents.

Authors:  B A Alman; A De Bari; J I Krajbich
Journal:  J Bone Joint Surg Am       Date:  1995-01       Impact factor: 5.284

View more
  5 in total

1.  Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up.

Authors:  Ferdiansyah Mahyudin; Kukuh Dwiputra Hernugrahanto; Jeffry Andrianus; Lukas Widhiyanto; Mouli Edward; Heri Suroto
Journal:  Indian J Orthop       Date:  2020-03-24       Impact factor: 1.251

2.  Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.

Authors:  Khodamorad Jamshidi; Mehdi Ramezan Shirazi; Abolfazl Bagherifard; Alireza Mirzaei
Journal:  Int Orthop       Date:  2018-08-11       Impact factor: 3.075

3.  Hemiarthroplasty of Pedicle-Frozen Proximal Tibia for Primary Malignant Bone Tumours.

Authors:  Suraj Hindiskere; Sreeraj Rajan; Utkarsh Pal; Pramatha P Dixit; Vaishnavi R Varma; Pramod S Chinder
Journal:  Indian J Orthop       Date:  2022-05-30       Impact factor: 1.033

4.  How Can We Differentiate Local Recurrence From Heterotopic Ossification After Resection and Implantation of an Oncologic Knee Prosthesis in Patients with a Bone Sarcoma?

Authors:  Khodamorad Jamshidi; Abolfazl Bagherifard; Hamadalla Hadi Al-Baseesee; Alireza Mirzaei
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

5.  Temporal hemiarthroplasty for distal femoral osteosarcoma in early childhood: a case report.

Authors:  Jungo Imanishi; Masayuki Tanabe; Taisei Kurihara; Tomoaki Torigoe; Jun Kikkawa; Atsuhiko Ohta; Atsuko Watanabe; Ryuhei Tanaka; Kazuo Saita; Yuho Kadono; Yasuo Yazawa
Journal:  World J Surg Oncol       Date:  2020-10-28       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.